nasdaqA Hong Kong Clothes Seller Is Pivoting Into Pharmaceutical Cannabis

707 Cayman Holdings sells clothing and manages supply chains from Hong Kong. On Monday it said it intends to acquire a pharmaceutical cannabis company.

The target is Crucial Innovation Inc., which describes itself as an integrated pharmaceutical botanical therapeutics platform. Medical cannabis is its commercial foundation; the company says it is also developing therapies in oncology, pain management and opioid replacement, and has established routes to market in the UK, Germany and Australia, according to the release. The term sheet is non-binding, and closing still requires satisfactory due diligence, delivery of audited financial statements, a fairness opinion, definitive agreements, and approval from shareholders, regulators and Nasdaq.

The proposed deal would be backed by $10.25 million in committed financing, led by GeoNova Holdings, an Abu Dhabi-based investment group, together with co-investors. The release says the funds are intended to cover transaction and growth costs. The acquisition price, valuation and allocation of proceeds have not been disclosed and will be set out in the definitive agreements.

Shares closed 77.88% higher at $6.7950 after the announcement, on dollar volume of about $126.6 million against a free float of about 570,000 shares.

No financial figures for Crucial Innovation appear in the release — no revenue, no cash, no valuation. The deal commits neither side to anything until definitive agreements are signed, a price is named and Nasdaq gives its approval.